BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35331571)

  • 41. Ultra-radical compartmentalized surgery in gynaecological oncology.
    Höckel M
    Eur J Surg Oncol; 2006 Oct; 32(8):859-65. PubMed ID: 16690243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical algorithm for the management of advanced pelvic tumours involving the aortoiliac axis.
    Rajendran S; Nguyen CL; Brown KGM; Solomon MJ
    Eur J Surg Oncol; 2023 Jul; 49(7):1317-1319. PubMed ID: 36964055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.
    Brown WE; Koh CE; Badgery-Parker T; Solomon MJ
    Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laparoscopic laterally extended endopelvic resection (LEER) for cervical carcinoma recurring at the pelvic sidewall after concurrent chemoradiotherapy: Our experience in three cases.
    Kanao H; Aoki Y; Hisa T; Takeshima N
    Gynecol Oncol; 2018 May; 149(2):428-429. PubMed ID: 29510867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
    Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
    Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy.
    Kaur M; Joniau S; D'Hoore A; Vergote I
    Curr Opin Oncol; 2014 Sep; 26(5):514-20. PubMed ID: 25050632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.
    Donati OF; Lakhman Y; Sala E; Burger IA; Vargas HA; Goldman DA; Andikyan V; Park KJ; Chi DS; Hricak H
    Eur Radiol; 2013 Oct; 23(10):2906-15. PubMed ID: 23652852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of imaging in pelvic exenteration for gynecological cancers.
    Causa Andrieu PI; Woo S; Rios-Doria E; Sonoda Y; Ghafoor S
    Br J Radiol; 2021 Sep; 94(1125):20201460. PubMed ID: 33960814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
    Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
    Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pelvic exenteration for advanced pelvic malignancy.
    Crowe PJ; Temple WJ; Lopez MJ; Ketcham AS
    Semin Surg Oncol; 1999; 17(3):152-60. PubMed ID: 10504662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
    Kanao H; Aoki Y; Hisa T; Takeshima N
    Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
    de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
    Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oncological pelvic surgery from a gynecological perspective].
    Höckel M
    Chirurg; 2010 Oct; 81(10):875-82. PubMed ID: 20628859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palliative Pelvic Exenteration for Pelvic Recurrence Invading the Sciatic Foramen with Chronic Cutaneous Perineal Fistula after Radical Surgery for Cervical Cancer: A Case Report.
    Bacalbasa N; Balescu I
    Anticancer Res; 2015 Sep; 35(9):4877-80. PubMed ID: 26254382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pelvic exenteration for advanced and recurrent malignancy.
    Zoucas E; Frederiksen S; Lydrup ML; Månsson W; Gustafson P; Alberius P
    World J Surg; 2010 Sep; 34(9):2177-84. PubMed ID: 20512493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.